To investigate if the sLex/E‐selectin mediated tumour adhesion to HUVECs was blocked by ALP in U‐2 OS cells, we examined the adhesion rate of U‐2 OS cells to HUVECs in response to different ALP treatment (0.5, 1 and 2 mg/mL) or not. The gene discussed is SELE; the disease is neoplasm.